Dermatological and Transdermal Formulations
1st Edition
Published on 20. February 2002
592 pages
978-0-8247-4323-9 (ISBN)
Description
Containing 350 illustrations, tables, and equations and covering AAPS/FDA guidelines for the experimentation and analysis of in vivo and in vitro percutaneous absorption, this reference provides comprehensive coverage of the development, preparation, and application of topical and transdermal therapeutic systems. Recognized international experts di
Reviews / Votes
"...a comprehensive overview....gathers the immense amount of information available on skin...in a very stepwise and clear way."-Pharmazie
"...useful addition to the literature...an impressive and authorative work. It is well laid out and easy on the eye, many clear diagrams and figures illustrate the text...a worthy reference work...should be on the bookshelf of everyone interested in this field."
-ISSX Newsletter
Promo Copy
More details
Edition
1. Auflage
Language
English
Place of publication
Baton Rouge
United States
Publishing group
Taylor & Francis Inc
Target group
Professional and scholarly
Cosmetic and pharmaceutical scientists, dermatologists, toxicologists, agrochemists, regulatory agency personnel, and upper-level undergraduate and graduate students in these disciplines
File size
11,39 MB
ISBN-13
978-0-8247-4323-9 (9780824743239)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Kenneth A. Walters
Dermatological and Transdermal Formulations
Book
10/2019
1st Edition
CRC Press
€87.50
Shipment within 15-20 days
Kenneth A. Walters
Dermatological and Transdermal Formulations
Book
02/2002
1st Edition
CRC Press
€280.50
Shipment within 15-20 days
Content
The structure and function of the skin; common skin disorders and their topical treatment; basic mathematical principles in skin permeation; skin transport; methods for studying percutaneous absorption; formulation strategies for modulating skinpermeation; formulation and development of dermatological dosage forms; bioequivalence of dermal and transdermal formulations; scale-up of dermatological dosage forms; a case for multivariate optimization and product homogeneity; transdermal drug deliverysystems; safety considerations for dermal and transdermal products; transdermal delivery and cutaneous reactions.
